Updating previous idea post. $GERN has not strayed from our troughs and did not fall through the $3.05 support . Created a projection line in black for possible expectations to break-even @ $3.23, possibly going positive to $3.30
News is neutral to negative with a reported earnings of $-0.05 per share, however the company has $146.7m in cash with positive outlook with Janssen Biotech.
Earnings Estimates Under Review.
News is neutral to negative with a reported earnings of $-0.05 per share, however the company has $146.7m in cash with positive outlook with Janssen Biotech.
Earnings Estimates Under Review.
Comentarios:
Morning spike, lots of premarket trading. Closed the position @ $3.31, gain of roughly $0.08-0.09 per share. Came out positive.
